Manufacturers: App pharmaceuticals llc, Ben venue laboratories inc +32 more
Folic acid is a nutrient used to treat megaloblastic anemia and is found in many supplements.
Folic acid is a nutrient used to treat megaloblastic anemia and is found in many supplements.
Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.
Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.
10 associated conditions
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
